diabetestalk.net

15 Wonderful Health Benefits Of Chili Peppers: Reduced Risk Of Diabetes And Cancer

15 Wonderful Health Benefits of Chili Peppers: Reduced Risk of Diabetes and Cancer

15 Wonderful Health Benefits of Chili Peppers: Reduced Risk of Diabetes and Cancer

Almost everyone knows chili peppers for their ‘heat’ or ‘spiciness’ but not a lot of people are aware of just how healthy this food is. Chili peppers offer a number of health benefits, which comes as no surprise considering the fact that they contain many different key nutrients. Chili peppers are noted for containing a good amount of vitamins A, B6, K1, and C, potassium, copper, iron, capsanthin, lutein, and capsaicin. The most important of all these nutrients is capsaicin, which is a plant compound responsible for many different health benefits of chili peppers. There are countless varieties of chili peppers, each with a different shape, color, heat factor, and unique flavor.
Top 15 Health Benefits of Chili Peppers
Top 15 Health Benefits of Chili Peppers
The insulin that’s required to lower your blood sugar levels after you eat a meal is significantly lower if the meal you eat contains chili peppers. Chili peppers are also known for increasing the rate at which the liver clears insulin in overweight people. This all contributes to a reduced risk of diabetes.
Chili peppers contain a very healthy bioactive plant compounds known as capsaicin. This compound is significant for your health because it binds with pain receptors, thus providing you with pain relief. However, you should know that consuming a lot of capsaicin can damage your pain receptors over time.
More specifically, chili peppers are known for helping protect you from prostate cancer. Capsaicin is responsible for this health benefit as well. This compound will help you by slowing down the growth of pros Continue reading

Rate this article
Total 1 ratings
SWEET ISSUES OR MEDICAL MARIJUANA IN TREATING DIABETES

SWEET ISSUES OR MEDICAL MARIJUANA IN TREATING DIABETES


SWEET ISSUES OR MEDICAL MARIJUANA IN TREATING DIABETES
Home OUR BLOG SWEET ISSUES OR MEDICAL MARIJUANA IN TREATING DIABETES
Our recent article was devoted to metabolic process in stimulating and regulating appetite. We made up our mind to continue metabolic topic in covering diabetes disease.
According to National Diabetes Statistics Report an estimated 23.1 million people or 7.2% of the U.S. population had diagnosed diabetes. And in 2015 diabetes was the 7th leading cause of death in the United States.
In spite of the fact, that diabetes isnt so popularized as a severe and dangerous disease like for instance cancer and its quite possible to live with diabetes normally, the staggering figures show that it should be concerned seriously. For simple people never faced diabetes this disease is associated with sugar, or its high level in the blood. Of course its not because of chocolate and sweets, but we have to consider sugar blood, called glucose.
To understand what diabetes is and how harmful it can be, we need to get the idea of how glucose is controlled. And it is the job of the hormone insulin, which is produced by the pancreas. Insulin is responsible for regulating sugar and fat from consumed food. Diabetes can develop if the pancreas produces little or no insulin (type 1 diabetes), or when there is insulin in our body, but it couldnt be accepted properly (type 2 diabetes).
The type 1 and type 2 diabetes may come out in (mainly for patients with untreated diabetes):
Diabetes may result in such chronic complications as:
nerve damage (which consequently may r Continue reading

The relationship between diabetes and pancreatic cancer

The relationship between diabetes and pancreatic cancer


The relationship between diabetes and pancreatic cancer
Wang et al; licensee BioMed Central Ltd.2003
About 80% of pancreatic cancer patients have glucose intolerance or frank diabetes. This observation has led to the following two hypotheses: i. pancreatic cancer causes the associated diabetes and ii. the conditions associated with diabetes promote the development of pancreatic cancer. Evidence supporting both hypotheses has been accumulated in previous studies. This article reviews these studies, especially those that have been conducted recently.
Pancreatic CancerPancreatic Cancer CellPancreatic Cancer Cell LinePancreatic Cancer PatientHuman Pancreatic Cancer Cell
The early symptoms of pancreatic cancer, such as abdominal pain, weight loss, fatigue, jaundice, and nausea, are nonspecific and may occur late in the course of the disease [ 1 , 2 ]. As a result, pancreatic cancer is usually diagnosed at an advanced stage, frequently after the tumor has already metastasized. Pancreatic cancer is insensitive to pharmacological and radiological intervention and often recurs after apparently curative surgery. All these factors contribute to the dismal prognosis of the disease [ 3 ].
About 80% of pancreatic cancer patients have glucose intolerance or frank diabetes [ 4 , 5 ]. This observation has led to the following two hypotheses: i. pancreatic cancer causes diabetes and ii. diabetes is a risk factor for the development of pancreatic cancer. Numerous studies have been performed in order to elucidate the relationship between these two diseases.
Evidence suggesting that pa Continue reading

Acute Kidney Injury in Diabetes Mellitus

Acute Kidney Injury in Diabetes Mellitus


Clinic of Nephrology and Rheumatology, University Hospital of Gttingen, Gttingen, Germany
Received 2016 May 26; Revised 2016 Sep 27; Accepted 2016 Oct 20.
Copyright 2016 D. Patschan and G. A. Mller.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Diabetes mellitus (DM) significantly increases the overall morbidity and mortality, particularly by elevating the cardiovascular risk. The kidneys are severely affected as well, partly as a result of intrarenal athero- and arteriosclerosis but also due to noninflammatory glomerular damage (diabetic nephropathy). DM is the most frequent cause of end-stage renal disease in our society. Acute kidney injury (AKI) remains a clinical and prognostic problem of fundamental importance since incidences have been increased in recent years while mortality has not substantially been improved. As a matter of fact, not many studies particularly addressed the topic AKI in diabetes mellitus. Aim of this article is to summarize AKI epidemiology and outcomes in DM and current recommendations on blood glucose control in the intensive care unit with regard to the risk for acquiring AKI, and finally several aspects related to postischemic microvasculopathy in AKI of diabetic patients shall be discussed. We intend to deal with this relevant topic, last but not least with regard to increasing incidences and prevalences of both disorders, AKI and DM.
The incidence and prevalence of di Continue reading

Dr. Aaron Vinik on Cycloset in Diabetes Treatment

Dr. Aaron Vinik on Cycloset in Diabetes Treatment


In part 4 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the untapped possibilities of Cycloset.
Aaron Vinik, MD, PhD, FCP, MACP is the Director of Research and Professor of Medicine, Pathology and Neurobiology at Eastern Virginia Medical School in Norfolk, Virginia. His research and recent discovery of a gene, INGAP, could prove to be a cure for diabetes.
Steve Freed: Three years ago, I asked you whats the most exciting things coming out of ADA and you said it was cycloset. I said cycloset? Its a postprandial drug, it reduces blood sugars insignificantly. Theres better drugs out there to reduce postprandial blood sugar. You said forget about postprandial blood sugars you reduce your risk for base by 55% percent. And now we know that SGLT2s it might be 35%, but nobody here is talking about cycloset and it showed to be much more effective. Now, is it because it was a smaller study? But even if it was why arent we seeing research or money being put into that to get the results out in a larger study because if its really 55% I mean it should be put in our drinking water.
Dr. Vinik: Now you put your finger on what the problem is. The problem is that was a safety study, it wasnt powered to do that and nor was it the primary endpoint. So you have the nay-sayers out there that say show us the money and what they mean by that is that the study is going to be conducted in such a way that this fulfills your primary endpoint. Thats one of the reasons why you cannot use the in Continue reading

No more pages to load

Popular Articles

Related Articles